A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors

Macquarie University Hospital Clinical Trials Unit, Sydney

Peter MacCallum Cancer Centre, Melbourne

Breast Cancer Research Centre - WA, Nedlands

University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh

Duke University, Durham

Sarah Cannon Research Institute/Tennessee Oncology, Nashville

MD Anderson Cancer Center, Houston

The START Center for Cancer Care, San Antonio

Massachusetts General Hospital, Boston

Seoul National University Hospital, Seoul

Asan Medical Center, Seoul

Samsung Medical Center, Seoul